Latest AI News

AI Accelerates Biotech Innovation to Overcome Labor Gaps

Biotech firms are turning to artificial intelligence to boost productivity and address talent shortages. Insilico Medicine is building a multi‑task AI platform that can generate disease hypotheses, design candidate molecules and even repurpose existing drugs, aiming to speed drug discovery and cut costs. GenEditBio is using AI to design engineered protein delivery vehicles that target specific tissues for in‑vivo CRISPR therapy, recently receiving FDA clearance for a corneal‑dystrophy trial. Both companies stress the need for richer, more diverse data to improve model accuracy and envision future tools such as digital twins for virtual clinical testing.

ChatGPT Helps User Refine 2026 Goals, Highlights Priorities and Risks

A writer recounts how they used ChatGPT as a goal‑setting coach for the year 2026. By feeding the AI a list of personal and professional objectives, the model identified blind spots, questioned assumptions about work capacity, pregnancy timing, and social commitments, and suggested ways to reduce cognitive load. The interaction led the author to prioritize a handful of non‑negotiables, restructure the yearly plan, and adopt new operating rules aimed at preserving stability over growth.

Backlash Over OpenAI's Retirement of GPT-4o Highlights Risks of AI Companions

OpenAI announced the retirement of its GPT-4o chatbot model, sparking a wave of user protest and raising concerns about the emotional bonds people form with AI. The move has triggered eight lawsuits alleging that the model provided harmful advice to vulnerable users. Experts warn that while AI companions can fill gaps in mental‑health access, they also risk fostering dependence and isolation. The controversy underscores the challenge of balancing supportive AI interactions with safety safeguards as the industry races to develop more emotionally intelligent assistants.

AI Chatbots Turn Users into Personalized Caricatures

A new online trend lets users request AI chatbots to create caricature illustrations that reflect both their appearance and personal details. By combining a selfie with a prompt, the model draws on prior conversation history and supplied information to add elements such as job cues, hobbies, pets and other quirks. The result is a whimsical, hand‑drawn style portrait that showcases how AI blends visual and textual data to produce personalized artwork.

OpenAI CEO Sam Altman Criticizes Anthropic’s Super Bowl Ads Targeting ChatGPT’s Ad‑Supported Tier

OpenAI chief Sam Altman publicly rebuked Anthropic after the rival released Super Bowl commercials that satirized OpenAI’s new ad‑supported version of ChatGPT. The ads portrayed AI assistants interrupting personal conversations with fictional product pitches, implying that ChatGPT would embed ads within its answers. Altman called the messaging “clearly dishonest” and warned that such portrayals could damage user trust. The clash highlights a growing debate over how AI companies can generate revenue without compromising the user experience, with OpenAI emphasizing ads that appear only at the bottom of responses and Anthropic positioning its Claude model as an ad‑free alternative.

Big Tech’s AI Capital‑Spending Race: Amazon Leads, Investors Wary

Amazon, Google, Microsoft, Meta and Oracle are pouring record capital into artificial‑intelligence infrastructure, data‑center expansion and related technologies. Amazon’s projected spend tops the list, followed closely by Google, while Microsoft, Meta and Oracle trail behind. Investors are uneasy about the size of the commitments, noting sharp stock declines for firms with the highest projected outlays. The clash between massive AI‑related capex and market comfort highlights a tension that could shape the industry’s future as companies race to secure compute resources.